Peptide-specific engagement of the activating NK cell receptor KIR2DS1

[1]  M. Altfeld,et al.  Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function. , 2016, Journal of hepatology.

[2]  M. Altfeld,et al.  Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 , 2016, Nature Immunology.

[3]  Daniel M. Davis,et al.  The Size of Activating and Inhibitory Killer Ig-like Receptor Nanoclusters Is Controlled by the Transmembrane Sequence and Affects Signaling , 2016, Cell reports.

[4]  Bas E. Dutilh,et al.  Dispersion of the HIV-1 Epidemic in Men Who Have Sex with Men in the Netherlands: A Combined Mathematical Model and Phylogenetic Analysis , 2015, PLoS medicine.

[5]  Jaclyn K. Mann,et al.  Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa , 2015, PLoS medicine.

[6]  Peter Parham,et al.  Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes , 2015, The Journal of Immunology.

[7]  Christopher R. Gignoux,et al.  Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population , 2015, PLoS genetics.

[8]  G. Smyth,et al.  Early Lineage Priming by Trisomy of Erg Leads to Myeloproliferation in a Down Syndrome Model , 2015, PLoS genetics.

[9]  Morten Nielsen,et al.  Uncovering the Peptide-Binding Specificities of HLA-C: A General Strategy To Determine the Specificity of Any MHC Class I Molecule , 2014, The Journal of Immunology.

[10]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[11]  M. Altfeld,et al.  Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03: 04 and modulate primary natural killer cell function , 2014, AIDS.

[12]  C. Fauriat,et al.  Activating Killer Cell Ig-Like Receptors in Health and Disease , 2014, Front. Immunol..

[13]  E. Ren,et al.  Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11 , 2014, Proceedings of the National Academy of Sciences.

[14]  C. Retière,et al.  Large Spectrum of HLA-C Recognition by Killer Ig–like Receptor (KIR)2DL2 and KIR2DL3 and Restricted C1 Specificity of KIR2DS2: Dominant Impact of KIR2DL2/KIR2DS2 on KIR2D NK Cell Repertoire Formation , 2013, The Journal of Immunology.

[15]  A. Sharkey,et al.  Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. , 2013, The Journal of clinical investigation.

[16]  C. Carcassi,et al.  Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients. , 2013, Experimental hematology.

[17]  M. Altfeld,et al.  Control of human viral infections by natural killer cells. , 2013, Annual review of immunology.

[18]  R. Welsh,et al.  NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections. , 2013, Virology.

[19]  Satya Sudheer Pydi,et al.  Killer cell immunoglobulin like receptor gene association with tuberculosis. , 2013, Human immunology.

[20]  M. Altfeld,et al.  HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function , 2012, Retrovirology.

[21]  J. Chewning,et al.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. , 2012, The New England journal of medicine.

[22]  D. Marin,et al.  KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib , 2012, Leukemia.

[23]  Todd M. Allen,et al.  HIV-1 adaptation to NK cell mediated immune pressure , 2011, Nature.

[24]  E. Romeo,et al.  Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT. , 2011, Blood.

[25]  M. Altfeld,et al.  Common HIV-1 Peptide Variants Mediate Differential Binding of KIR3DL1 to HLA-Bw4 Molecules , 2011, Journal of Virology.

[26]  S. Agrawal,et al.  Killer immunoglobulin-like receptors (KIRs) and HLA-C allorecognition patterns implicative of dominant activation of natural killer cells contribute to recurrent miscarriages. , 2011, Human reproduction.

[27]  F. Locatelli,et al.  Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. , 2011, Blood.

[28]  Chap T Le,et al.  Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. , 2010, Blood.

[29]  N. Wauquier,et al.  Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection , 2010, Immunogenetics.

[30]  F. Rieux-Laucat,et al.  Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. , 2010, Clinical immunology.

[31]  M. Martinetti,et al.  Anti-Leukemia Activity of Alloreactive NK Cells in Haploidentical HSCT in Pediatric Patients: Re-Defining the Role of Activating and Inhibitory KIR , 2008 .

[32]  Eric Vivier,et al.  Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Campana,et al.  Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. , 2005, Blood.

[34]  P. Parham.  MHC class I molecules and kirs in human history, health and survival , 2005, Nature Reviews Immunology.

[35]  Milena Ivanova,et al.  Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals , 2005, Cancer Immunology, Immunotherapy.

[36]  D. Lake,et al.  Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries , 2004, Immunogenetics.

[37]  M. Mańczak,et al.  Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. , 2004, Human immunology.

[38]  T. Sasazuki,et al.  Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. , 2004, The Journal of investigative dermatology.

[39]  Michael J. Wilson,et al.  Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1 , 2002, The Journal of Immunology.

[40]  P. Sun,et al.  A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. , 2002, Molecular immunology.

[41]  Eric O Long,et al.  Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1–HLA-Cw4 complex , 2001, Nature Immunology.

[42]  Jeffrey C. Boyington,et al.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand , 2000, Nature.

[43]  D. Stuart,et al.  Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. , 1999, Structure.

[44]  J. Strominger,et al.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Jun Wu,et al.  Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.

[46]  R. Biassoni,et al.  Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA‐Cw4 molecules , 1997, European journal of immunology.

[47]  Eric O Long,et al.  The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity , 1997, The Journal of experimental medicine.

[48]  Robyn L. Stanfield,et al.  An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.

[49]  V. Gnau,et al.  Allele-specific peptide ligand motifs of HLA-C molecules. , 1993, Proceedings of the National Academy of Sciences of the United States of America.